Solid Biosciences Inc. held its Annual Meeting of Stockholders on June 12, 2025. The stockholders elected Alexander Cumbo and Sukumar Nagendran as Class I directors. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An amendment to the 2020 Equity Incentive Plan to increase the number of shares available for issuance by 9,000,000 and amend the evergreen provision was approved. Additionally, a non-binding advisory vote on the compensation paid to named executive officers was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.